About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
British Journal of Haematology
›
Top Articles
British Journal of Haematology
Hematology
4.5
(top 3%)
Impact Factor
4.9
(top 3%)
extended IF
211
(top 1%)
H-Index
9.9K
authors
24K
papers
717.3K
citations
9.8K
citing journals
129.2K
citing authors
Most Cited Articles of British Journal of Haematology
Title
Year
Citations
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group
1976
4.5K
Proposals for the classification of the myelodysplastic syndromes
1982
2.9K
Proposals for the classification of the myelodysplastic syndromes
1982
2.1K
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
2003
1.5K
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma
2008
1.4K
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant
1998
1.2K
Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)
1991
1.2K
Mesenchymal progenitor cells in human umbilical cord blood
2000
1.2K
The nature and significance of platelet products in human plasma
1967
1K
Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo
1970
825
The autoxidation of human red cell lipids induced by hydrogen peroxide
1971
760
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
2009
752
Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells
2005
738
Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate
1999
738
Preparation of suspensions of washed platelets from humans
1972
726
The interactions between inflammation and coagulation
2005
679
Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant
2004
629
Tumour lysis syndrome: new therapeutic strategies and classification
2004
628
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group
2003
624
Thrombophilia in pregnancy: a systematic review
2006
622
Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy
2003
593
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
2004
562
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)
1991
543
Proposals for the classification of the myelodysplastic syndromes
1982
531
Bone marrow angiogenesis and progression in multiple myeloma
1994
525
previous
2006
2007
2008
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.